Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)

Clinical trial NCT07579429 · RECRUITING

Trial details

NCT number: NCT07579429
Sponsor: University of Colorado, Denver
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clonal Cytopenia of Undetermined Significance Myelodysplastic Syndrome

Start date: 2026-05-20
Primary completion: 2029-12-18
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.